Deep search
Rewards
Search
All
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
My Bing
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Politics
Business
Trending on Bing
Comer invites Biden to testify
Sentenced to 25 years
Removes human skin binding
Surveys on US landfills
Election interference hearing
Police clash over US cadets
Hawaii jet fuel drained
Palestinian Cabinet reform
Venezuelans stuck in Mexico
St. Vincent announces tour
Russia vetoes UN resolution
Calls for acts of friendship
Ventura to sell cannabis
Offers free premium features
Ship pilot's tugboat request
Senate trial for Mayorkas
'Ghost guns' ban advanced
Attends NYPD officer's wake
S. Africa bus crash kills 45
US pending home sales rose
‘Mayor of Kingstown' trailer
Census on race, ethnicity
Appears in better health
Timberwolves sale falls apart
Support pledged for Taiwan
Biden OKs $60M in aid
Jackpot jumps to $935M
Expand strategic partnership
S&P 500 rises to new record
Invited to Olympic camp
Jobless claims dip to 210,000
'EGGucation' theme again
US Q4 GDP growth revised
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
12d
on MSN
Failure of ALS drug puts a spotlight on controversial FDA approvals
A large clinical trial found that Amylyx Pharmaceuticals’ drug to treat ALS doesn’t work, raising questions about the FDA’s process for approving it.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback